Bio

Diyong Xu is a Principal on the Private Equity team. Prior to joining OrbiMed, Mr. Xu was an investment banking analyst in the healtDiyong is a Principal on the Private Equity team and has been with OrbiMed since 2012. Prior to joining OrbiMed, Diyong was an investment banking analyst in the healthcare group at Lazard where he focused on M&A, financing, and strategic advisory for biotech, diagnostics, and pharma clients in the U.S., Japan, and E.U. Diyong earned his M.S. degree in Management Science and Engineering from Stanford University and M.S. degree in Molecular and Cellular Biology from Dartmouth College. He holds a B.S. degree in Biology from Zhejiang University in China. Outside the office, he enjoys playing tennis and basketball.